{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:47:01Z","timestamp":1786373221807,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.2215\/cjn.09860721","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T10:17:43Z","timestamp":1631096263000},"page":"1315-1317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gene Expression Profiling in Kidney Transplant Recipients on Immune Checkpoint Inhibitors"],"prefix":"10.2215","volume":"16","author":[{"given":"Priyanka","family":"Jethwani","sequence":"first","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Division of Transplantation Surgery and Immunology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree C.","family":"Shirali","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.2018050488","article-title":"Nephrotoxicity of cancer immunotherapies: Past, present and future","volume":"29","author":"Perazella","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2215\/CJN.00920121","article-title":"Gene expression profiling in kidney transplants with immune checkpoint inhibitor\u2013associated adverse events","volume":"16","author":"Adam","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"656353","DOI":"10.3389\/fmicb.2021.656353","article-title":"Antiviral activity of interferon alpha-inducible protein 27 against hepatitis B virus gene expression and replication","volume":"12","author":"Ullah","year":"2021","journal-title":"Front Microbiol"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"1602098","DOI":"10.1183\/13993003.02098-2016","article-title":"A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection","volume":"49","author":"Tang","year":"2017","journal-title":"Eur Respir J"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/CMAR.S196485","article-title":"Interferon \u03b1-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival","volume":"11","author":"Chiang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/annonc\/mdy399","article-title":"Immunological differences between primary and metastatic breast cancer","volume":"29","author":"Szekely","year":"2018","journal-title":"Ann Oncol"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","article-title":"Gene expression profiling for the identification and classification of antibody-mediated heart rejection","volume":"135","author":"Loupy","year":"2017","journal-title":"Circulation"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.09860721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:45Z","timestamp":1786369425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.09860721"}},"subtitle":["More than Meets the Eye"],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.09860721","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}